Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Surg Neurol Int ; 13: 201, 2022.
Article in English | MEDLINE | ID: mdl-35673678

ABSTRACT

Background: Primary solitary plasmacytoma (PSP) of the skull base is a rare localized monoclonal plasma cell dyscrasia with normal or low plasma cell infiltration. Differentiating from other skull base tumors based on radiologic findings is difficult due to nonspecific features. PSP has a better prognosis after surgical resection and adjuvant radiotherapy, unless the tumor progresses to multiple myeloma (MM). Nonetheless, 50-60% progress to MM within a median time of 2 years. Gross total resection (GTR) for PSP is controversial for improving overall survival. However, if the lesion is easily accessible, for example, nonskull base lesion, GTR is still advocated. Case Description: A 67-year-old male patient presented with right occipital neuralgia and diplopia in the last year. Neurological examination revealed mild abducens paresis on the right side. Brain MRI scan showed a large petroclival bony extradural mass lesion on the right side, with homogeneous enhancement, extending from the dorsum sellae to the ipsilateral occipital condyle and involving the petrous carotid artery. Brain CT scan revealed an osteolytic lesion without intratumoral calcifications, sclerotic border, or periosteal reaction. Anterior petrosal approach was performed and GTR was achieved. The patient had good postoperative outcome and improvement of symptoms. Postoperative MRI revealed GTR. Total body imaging work-up and immunohistochemistry confirmed PSP. Conclusion: Although the extent of resection in the outcome is controversial, maximal safe resection of skull base PSP should be considered to improve symptoms and quality of life.

SELECTION OF CITATIONS
SEARCH DETAIL
...